Search Ontology:
ChEBI
(2R,3S,4S,5R,6R)-4,6-Dihydroxy-3-[(2R,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(sulfoamino)-4-sulfooxyoxan-2-yl]oxy-5-sulfooxyoxane-2-carboxylic acid
- Term ID
- CHEBI:153097
- Synonyms
-
- 2-deoxy-3-O-sulfo-2-sulfoamino-alpha-D-gluco-hexopyranosyl-(1->4)-2-O-sulfo-alpha-L-ido-hexopyranuronic acid
- GlcNS3S(a1-4)a-IdoA2S
- WURCS=2.0/2,2,1/[a2121A-1a_1-5_2*OSO/3=O/3=O][a2122h-1a_1-5_2*NSO/3=O/3=O_3*OSO/3=O/3=O]/1-2/a4-b1
- Definition
- References
-
- GlyGen:G68366MI
- GlyTouCan:G68366MI
- Ontology
- ChEBI ( EBI )
- is a type of
-
Show first 5 Terms
Phenotype
Phenotype resulting from (2R,3S,4S,5R,6R)-4,6-Dihydroxy-3-[(2R,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(sulfoamino)-4-sulfooxyoxan-2-yl]oxy-5-sulfooxyoxane-2-carboxylic acid
Phenotype where environments contain (2R,3S,4S,5R,6R)-4,6-Dihydroxy-3-[(2R,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(sulfoamino)-4-sulfooxyoxan-2-yl]oxy-5-sulfooxyoxane-2-carboxylic acid
Phenotype modified by environments containing (2R,3S,4S,5R,6R)-4,6-Dihydroxy-3-[(2R,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(sulfoamino)-4-sulfooxyoxan-2-yl]oxy-5-sulfooxyoxane-2-carboxylic acid
Human Disease Model